This retrospective analysis examines filled naloxone prescriptions among patients receiving buprenorphine treatment and assesses how rates of filled naloxone prescriptions varies by patient, prescriber, and community characteristics.
We analyze substance use, AI/AN cultural identity and involvement, physical health and cognitive functioning, and mental health symptoms among 63 AI/AN adults seeking substance use treatment within an urban area in California.
This cross-sectional study examined how transaction sales limits on recreational cannabis translate to tetrahydrocannabinol doses among U.S. states allowing commercial cannabis sales as of January 1, 2020.
This study identifies distinct patterns (classes) of substance use among 30- to 80-year olds, identifies demographic subgroups with the highest probability of class memberships, and compares classes on key indicators of functioning.
Sleep science has traditionally viewed sleep as an individual phenomenon. But how well (or poorly) we sleep is clearly tied to the quality of our closest relationships. COVID-19 has further highlighted the critical importance of both healthy sleep and healthy relationships.
More than 2,000 plaintiffs have joined the largest civil trial in U.S. history: National Prescription Opiate Litigation (MDL 2804). In this virtual symposium, experts discuss the opioid litigation and its effects on the future of mass litigation.
In this RAND Remote presentation, Beau Kilmer discusses how RAND is identifying and evaluating innovative approaches to tackle some of America's most pressing drug problems and help strengthen and safeguard communities.
While many illegally manufactured potent synthetic opioids (IMPSO) are produced in Asia, there is little evidence they have entered markets there. We consider the susceptibility to IMPSO's encroachment in markets in the Asia-Pacific region.
This weekly recap focuses on keeping COVID-19 vaccines moving to save more lives; why we need a national commission to investigate the U.S. Capitol attack; media literacy as a tool to counter “Truth Decay,” and more.
In this paper, we provide an overview of methodological challenges facing opioid policy researchers when conducting opioid policy evaluation studies using observational data, as well as some potential solutions to those challenges.